abstract |
The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyI)-1-alkanone derivatives of formula (I): n n n n n n n n n n wherein A, W, R2 and n are as defined in the disclosure, to the method of preparation thereof and the therapeutic use thereof. |